A Cascade Model for Restenosis: A Special Case of Atherosclerosis Progression

BackgroundRestenosis presently limits the long-term success of percutaneous transluminal coronary angioplasty (PTCA) and allied treatments of atheroma. Current views of the pathophysiology of restenosis fail to explain certain important clinical features: Thrombosis, often invoked as a cause of smooth muscle proliferation, wanes before intimal thickening peaks. Prolonged antithrombotic therapy does not eliminate restenosis after PTCA. Furthermore, only a minority of angioplastied lesions develop clinically significant restenosis. Methods and ResultsWe propose a cytokine-growth factor cascade mechanism of restenosis pathobiology that could explain these features of human restenosis. According to this model, PICA would produce acute local thrombosis and/or mechanical injury that triggers cytokine/growth factor gene expression by resident macrophages and smooth muscle cells. This early acute generation of cytokines could evoke a secondary growth factor and cytokine response that might establish a positive, selfstimulatory autocrine and paracrine feedback loop that would serve to amplify and sustain the proliferative response. This multistage schema would account for the lag between injury and restenosis and the failure of chronic antithrombotic therapy to prevent this process. Human atheromata contain variable numbers of macrophages. The macrophage content of a particular lesion could determine in part propensity to develop restenosis after angioplasty, explaining why all lesions do not develop this process ConclusionsSeveral experimental observations support this novel mechanistic model. Leukocytes and smooth muscle cells express genes for cytokines and growth factors, and products of coagulation and thrombosis can activate mononuclear phagocytes. Cytokines and growth factors often augment their own gene expression and induce one another, providing a potential intralesional amplification loop. Experimental atheroma and advanced human atherosclerotic lesions do not express high levels of growthstimulatory cytokines such as interleukin-1 or tumor necrosis factor in the basal state but exhibit inducible expression in response to an injurious stimulus. Thus, cascades of autocrine or paracrine mediators whose expression is triggered by vascular injury might contribute to deranged smooth muscle behavior during restenosis.

[1]  P. Libby,et al.  Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  V. Ord,et al.  Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. , 1992, The American journal of pathology.

[3]  P. Libby,et al.  Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. , 1992, Experimental cell research.

[4]  P. Libby,et al.  Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.

[5]  P. Libby,et al.  Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae. , 1992, The Journal of nutrition.

[6]  B. Rollins,et al.  JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. , 1992, Circulation research.

[7]  S. Schwartz,et al.  Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. , 1992, The Journal of clinical investigation.

[8]  S. Coughlin,et al.  Monocyte chemoattractant protein-1 in human atheromatous plaques. , 1991, The Journal of clinical investigation.

[9]  M. Reidy,et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.

[10]  P. Libby,et al.  Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  M. Reidy,et al.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  U. Ikeda,et al.  Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. , 1991, The American journal of physiology.

[13]  P. Libby,et al.  Interleukin-1 gene expression in rabbit vascular tissue in vivo. , 1991, The American journal of pathology.

[14]  M. Klagsbrun,et al.  A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF , 1991, Science.

[15]  M. Nobuyoshi,et al.  Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. , 1991, Journal of the American College of Cardiology.

[16]  S. Schwartz,et al.  PDGF ligand and receptor gene expression during repair of arterial injury , 1990, The Journal of cell biology.

[17]  J. Miano,et al.  Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. , 1990, The American journal of pathology.

[18]  C. Geczy,et al.  Thrombin and factor Xa enhance the production of interleukin-1. , 1990, Immunology.

[19]  K. Karsch,et al.  Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. , 1990, Circulation research.

[20]  R. Ross,et al.  Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. , 1990, Arteriosclerosis.

[21]  A. Clowes,et al.  Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. , 1990, The American journal of pathology.

[22]  R. E. Pitas,et al.  Expression of the acetyl low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells. Up-regulation by phorbol esters. , 1990, The Journal of biological chemistry.

[23]  S. Schwartz,et al.  Cell proliferation in human coronary arteries. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Fishbein,et al.  Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. , 1990, Circulation research.

[25]  Leonard,et al.  Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. , 1990, The American journal of pathology.

[26]  G. Wilner,et al.  Thrombin binds to murine bone marrow-derived macrophages and enhances colony-stimulating factor-1-driven mitogenesis. , 1990, The Journal of biological chemistry.

[27]  B. Waller,et al.  Morphologic observations late after coronary balloon angioplasty: mechanisms of acute injury and relationship to restenosis. , 1990, Radiology.

[28]  P. Libby,et al.  Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. , 1990, The Journal of clinical investigation.

[29]  J. Winkles,et al.  Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression. , 1990, The Journal of biological chemistry.

[30]  J. Simpson,et al.  Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study. , 1990, Journal of the American College of Cardiology.

[31]  M. Reidy,et al.  Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Reidy,et al.  Regrowth of arterial endothelium. Denudation with minimal trauma leads to complete endothelial cell regrowth. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[33]  P. Libby,et al.  Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1. , 1989, Cellular immunology.

[34]  G. Liau,et al.  Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. , 1989, The Journal of biological chemistry.

[35]  M. Aviram Platelet secretory products enhance LDL receptor activity and inhibit scavenger receptor activity in human monocyte derived macrophages. , 1989, Metabolism: clinical and experimental.

[36]  B. Waller "Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders and melters"--the future treatment of atherosclerotic coronary artery disease? A clinical-morphologic assessment. , 1989, Journal of the American College of Cardiology.

[37]  P. Libby,et al.  Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[38]  S. Dower,et al.  Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. , 1989, Science.

[39]  P. Libby,et al.  Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. , 1989, Journal of immunology.

[40]  A. Clowes,et al.  Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. , 1988, Circulation research.

[41]  M J Banda,et al.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.

[42]  L Schwartz,et al.  Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. , 1988, The New England journal of medicine.

[43]  P. Libby,et al.  Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. , 1988, The New England journal of medicine.

[44]  M. Sporn,et al.  Induction of transforming growth factor-α in activated human alveolar macrophages , 1988, Cell.

[45]  D. Gospodarowicz,et al.  Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells. , 1988, European journal of cell biology.

[46]  P. Libby,et al.  Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. , 1988, The Journal of clinical investigation.

[47]  P W Serruys,et al.  Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. , 1988, Circulation.

[48]  J. Winkles,et al.  Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Heldin,et al.  Possible positive autocrine feedback in the prereplicative phase of human fibroblasts , 1987, Nature.

[50]  P. Libby,et al.  Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells , 1987, The Journal of experimental medicine.

[51]  C. Nathan,et al.  Secretory products of macrophages. , 1987, The Journal of clinical investigation.

[52]  P. Libby,et al.  Inducible interleukin-1 gene expression in human vascular smooth muscle cells. , 1986, The Journal of clinical investigation.

[53]  P. Libby,et al.  Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.

[54]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[55]  Gary R. Grotendorst,et al.  Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity , 1986, Nature.

[56]  R. Ross,et al.  A significant part of macrophage-derived growth factor consists of at least two forms of PDGF , 1985, Cell.

[57]  V. Fuster,et al.  Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. , 1985, Circulation research.

[58]  C. Heldin,et al.  Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.

[60]  G. Majno,et al.  Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. , 1983, The American journal of pathology.

[61]  R. Ross,et al.  Synthesis of types I and III procollagen and collagen by monkey aortic smooth muscle cells in vitro. , 1977, Biochemistry.

[62]  D. S. Neblock,et al.  In vivo technetium-99m S12 antibody imaging of platelet alpha-granules in rabbit endothelial neointimal proliferation after angioplasty. , 1991, Circulation.

[63]  J. Winkles,et al.  Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[64]  W. Wagner Modification of Collagen and Elastin in the Human Atherosclerotic Plaque , 1990 .

[65]  A. Lusis,et al.  Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis. , 1990, Journal of lipid research.

[66]  P. Libby,et al.  Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells. , 1989, Lymphokine research.

[67]  T. Wight,et al.  Cell biology of arterial proteoglycans. , 1989, Arteriosclerosis.

[68]  M. Reidy,et al.  Regulation of Smooth Muscle Cell Growth in Injured Artery , 1989, Journal of cardiovascular pharmacology.

[69]  M. Nobuyoshi,et al.  Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. , 1988, Journal of the American College of Cardiology.

[70]  M. Reidy,et al.  Basic Fibroblast Growth Factor Stimulates Endothelial Regrowth and Proliferation in Denuded Arteries , 2022 .